StockNews.com lowered shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Rating) from a strong-buy rating to a buy rating in a report released on Friday morning. A number of other equities research analysts also recently issued reports on the company. Needham & Company LLC lowered their price target on Jazz Pharmaceuticals from $210.00 to $205.00 and […]